OSAKA/TOKYO -- Japanese drugmaker Sumitomo Pharma has applied for approval in Japan of a stem cell-based Parkinson's disease treatment, it announced on Tuesday, looking to ease the motor symptoms of sufferers and help push the country's stem cell treatment implementation forward.
Pharmaceuticals
Sumitomo Pharma files for approval of stem cell Parkinson's treatment
Therapy improved motor function in 4 of 6 patients in clinical trial
Induced pluripotent stem cell technology was developed in Japan in 2007, but progress on developing treatments for diseases has been slow. (Photo obtained by Nikkei)
Read Next
Latest on Pharmaceuticals
